Tomosada Yoshikawa

Director/Miembro de la Junta en KLAB INC. .

57 años

Health Technology

Consumer Services

Technology Services

Cargos activos de Tomosada Yoshikawa

Empresas	Cargo	Inicio	Fin
KLAB INC.	Director/Miembro de la Junta	25/03/2018	-
KLAB INC.	Independent Dir/Board Member	25/03/2018	-
SUS CO.,LTD.	Director/Miembro de la Junta	01/12/2018	-
SUS CO.,LTD.	Corporate Officer/Principal	01/10/2018	-
Cross Reality Co., Ltd.	Director/Miembro de la Junta	01/09/2019	-

Empresas	Cargo	Inicio	Fin
TELLA, INC.	Director/Miembro de la Junta	01/03/2018	27/03/2019
TELLA, INC.	Independent Dir/Board Member	01/03/2018	27/03/2019
TAIKO PHARMACEUTICAL CO.,LTD.	Director Administrativo	01/06/2009	-
	Director/Miembro de la Junta	01/06/2007	-
	Director Financiero/CFO	04/01/2011	01/06/2013
	Contacto de Relaciones con Inversores	01/06/2009	-

Kwansei Gakuin University	Undergraduate Degree
Babson College	Masters Business Admin

Internacional

Japón	7
Estados Unidos	2

Operativa

Director/Board Member	5
Independent Dir/Board Member	2
Chief Administrative Officer	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	2
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology
Cross Reality Co., Ltd.

Empresas privadas

Health Technology

Cross Reality Co., Ltd.